Not sure if CAS intended to post this significant new (pre-)announcement to lists next week, but I am taking the liberty of doing so now. "Darwin is a visionary development initiative of CAS Innovation. Darwin uncovers novel relationships between biological targets and chemical entities within multiple sources to provide a unique view of disease landscapes." http://www.cas.org/products/lifesciences Being nth to market is not always a disaster, but if Darwin is taking on ChEMBL etc. (with a significant price difference :-) ), we live in interesting times. Wendy Dr. Wendy A. Warr Wendy Warr & Associates 6 Berwick Court, Holmes Chapel Cheshire, CW4 7HZ, England Tel./Fax +44 (0)1477 533837 wendy@warr.com<mailto:wendy@warr.com> http://orcid.org/0000-0002-7064-4739 http://www.warr.com<http://www.warr.com/> Skype: wendyannewarr Twitter: @WendyAnneWarr